International Stem Cell Corp. Announces Annual Meeting of Stockholders on June 11, 2024

TL;DR

<b>International Stem Cell Corporation will hold its virtual Annual Meeting of Stockholders on June 11, 2024, encouraging participation through online voting and discussion.</b>

AI Summary

International Stem Cell CORP (ISCO) filed a Proxy Statement (DEF 14A) with the SEC on April 25, 2024. The Annual Meeting of Stockholders for International Stem Cell Corporation will be held virtually on June 11, 2024, at 10:00 a.m. Pacific Time. Stockholders can attend the meeting online at www.proxydocs.com/ISCO to listen live, submit questions, and vote. The company is distributing a Notice of Annual Meeting of Stockholders and a Proxy Statement detailing the formal business. An Annual Report to Stockholders is also enclosed for informational purposes. The meeting will include a review of the company's past year's activities and future plans.

Why It Matters

For investors and stakeholders tracking International Stem Cell CORP, this filing contains several important signals. This meeting is a crucial opportunity for shareholders to actively participate in the company's governance and decision-making processes. The virtual format aims to increase accessibility for stockholders to engage with management and vote on important company matters.

Risk Assessment

Risk Level: low — International Stem Cell CORP shows low risk based on this filing. The filing is a routine proxy statement (DEF 14A) for an annual meeting, containing standard disclosures and no immediate material events or financial performance data.

Analyst Insight

Stockholders should review the proxy statement and annual report to make informed voting decisions regarding the election of directors and other business to be conducted at the annual meeting.

Key Numbers

• June 11, 2024 — Annual Meeting Date (Date of the Annual Meeting of Stockholders.)
• 10:00 a.m. Pacific Time — Annual Meeting Time (Time of the Annual Meeting of Stockholders.)
• 20240425 — Filing Date (Date the DEF 14A filing was made.)

Key Players & Entities

• International Stem Cell Corporation (company) — Registrant name and company holding the annual meeting.
• June 11, 2024 (date) — Date of the Annual Meeting of Stockholders.
• Andrey Semechkin, PhD (person) — Chief Executive Officer and Co-Chairman of International Stem Cell Corporation.
• www.proxydocs.com/ISCO (url) — Website for attending the virtual annual meeting.
• DEF 14A (document) — Filing type for the proxy statement.

FAQ

Industry Context

International Stem Cell Corporation operates in the pharmaceutical preparations industry, focusing on stem cell-related therapies.

Regulatory Implications

The filing is made under Section 14(a) of the Securities Exchange Act of 1934, governing proxy solicitations.

What Investors Should Do

1. Review the Proxy Statement for details on director nominees and other proposals.
2. Vote your shares by proxy, phone, or internet to ensure your participation.
3. Attend the virtual Annual Meeting on June 11, 2024, to engage with management and ask questions.

Key Dates

• 2024-06-11: Annual Meeting of Stockholders — Key date for shareholders to vote and participate in company affairs.
• 2024-04-25: Filing Date of DEF 14A — Date the proxy statement was officially filed with the SEC.

Year-Over-Year Comparison

This is a DEF 14A filing for the 2024 annual meeting, providing information typically found in such annual proxy statements.

Filing Documents

• isco-2024_proxy-def14a_n.htm (DEF 14A) — 570KB
• img155352719_0.jpg (GRAPHIC) — 74KB
• img155352719_1.jpg (GRAPHIC) — 74KB
• img155352719_2.jpg (GRAPHIC) — 113KB
• img155352719_3.jpg (GRAPHIC) — 100KB
• img155352719_4.jpg (GRAPHIC) — 2063KB
• img155352719_5.jpg (GRAPHIC) — 1044KB
• 0000950170-24-048331.txt (&nbsp;) — 5348KB

EXECUTIVE COMPENSATION

EXECUTIVE COMPENSATION 11 RELATED PERSON TRANSACTIONS 21 STOCK OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS 22 STOCKHOLDER PROPOSALS TO BE PRESENTED AT NEXT ANNUAL MEETING 23 TRANSACTION OF OTHER BUSINESS 23 DELIVERY OF PROXY MATERIALS AND ANNUAL REPORTS 23 i 9745 Businesspark Ave San Diego, California 92131 NOTICE OF ANNUAL MEETING OF STOCKHOLDERS TO BE HELD JUNE 11, 2024 TO OUR STOCKHOLDERS: Notice is hereby given that the Annual Meeting of the Stockholders of International Stem Cell Corporation, a Delaware corporation, will be held on June 11, 2024, at 10:00 a.m. Pacific Time. The Annual Meeting will be a virtual meeting. You can attend the Annual Meeting by visiting www.proxydocs.com/ISCO where you will be able to listen to the meeting live, submit questions and vote online. We are holding the Annual Meeting for the following purposes, as more fully described in the accompanying Proxy Statement: 1. To elect four directors (two of whom will be elected by a vote of the holders of Series D Preferred Stock) to hold office for a one-year term and until their respective successors are elected and qualified. 2. To transact such other business as may properly come before the meeting. All of our stockholders of record as of April 15, 2024, are entitled to attend and vote at the Annual Meeting and at any adjournment or postponement of the Annual Meeting. To participate in the Annual Meeting virtually via the Internet, please visit www.proxydocs.com/ISCO . In order to attend, you must register in advance at www.proxydocs.com/ISCO prior to the deadline of June 7, 2024 at 5:00 p.m., Eastern Time. Upon completing your registration, you will receive further instructions via email, including your unique links that will allow you access to the meeting and to submit questions during the meeting. You will not be able to attend the Annual Meeting in person. Andrey Semechkin, PhD Chief Execu

View Full Filing

View this DEF 14A filing on SEC EDGAR